Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Highly purified HMG versus HMG-based ovarian stimulation in IVF-ET
ChiCTR-OPR-15006204Phase 4Not yet recruiting
- Sponsor
- Northwest Women's and Children's Hospital
- Start
- May 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of human menopausal gonadotrophin and recombinant human follicle stimulating hormone in infertility (2 arms), sponsored by Northwest Women's and Children's Hospital. Primary endpoint: pregnancy rate. Planned start May 2015; status: not yet recruiting.
02
Drugs
human menopausal gonadotrophinrecombinant human follicle stimulating hormone
03
Conditions
infertility
Beyond the preview
Go deeper on ChiCTR-OPR-15006204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPR-15006204.